UroGen Pharma (URGN) Gross Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
UroGen Pharma (URGN) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 569.00 |
| 10 | UroGen Pharma | 2.23 Bn | 2.12 Bn | 65.88 Mn | 249.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249.00 |
| Mar 31, 2026 | 505.00 |
| Dec 31, 2025 | 382.00 |
| Sep 30, 2025 | 62.00 |
| Jun 30, 2025 | -354.00 |
| Mar 31, 2025 | -26.00 |
| Dec 31, 2024 | -23.00 |
| Sep 30, 2024 | 123.00 |
| Jun 30, 2024 | 75.00 |
| Mar 31, 2024 | 278.00 |
| Dec 31, 2023 | -153.00 |
| Sep 30, 2023 | -242.00 |
| Jun 30, 2023 | 135.00 |
| Jun 30, 2022 | -1,112.00 |
| Sep 30, 2021 | 36,183.00 |
| Jun 30, 2021 | 7,641.00 |
| Mar 31, 2021 | 7,741.00 |
| Dec 31, 2020 | 7,958.00 |
| Sep 30, 2020 | -515.00 |